openPR Logo
Press release

Dysmenorrhea Treatment Market Outlook 2029: Presents Market Insights & Depth Analysis

10-17-2023 09:21 AM CET | Health & Medicine

Press release from: Orion Market Research

Dysmenorrhea Treatment Market Outlook 2029: Presents Market

Dysmenorrhea Treatment Market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period . Dysmenorrhea is a common gynaecological condition that affects women of all ages and races. It is one of the most commonly diagnosed causes of pelvic pain in women. The symptoms associated with dysmenorrhea include gastrointestinal symptoms such as diarrhoea, nausea, bloating, constipation, or both, along with vomiting and indigestion. According to the National Centre for Biotechnology Information the prevalence of dysmenorrhea can vary between 16% and 91% in women of reproductive age, with severe pain observed in 2% to 29%. Dysmenorrhea is associated with significant impairment in quality of life between 16% to 29% of women. Furthermore, 12% of the monthly school and work activities are lost due to absenteeism because of dysmenorrhea. 

Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in May 2020, Mochida Pharmaceutical Co., Ltd announced the launch of DINAGEST Tablets 0.5 mg a therapeutic agent for dysmenorrhea. DINAGEST Tablets 1 mg, a therapeutic agent for endometriosis, was licensed from Jenapharm, a subsidiary of Bayer AG, and developed by Mochida. The drug is marketed in Japan since 2008 and an additional indication, reduction of pain caused by adenomyosis. 

To Request a Sample of our Report on Dysmenorrhea Treatment Market:  https://www.omrglobal.com/request-sample/dysmenorrhea-treatment-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Treatment Type
By Type

Regions Covered

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd. 

Dysmenorrhea Treatment Market Report by Segment

By Treatment Type.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Hormonal Therapy 

By Type 

Primary Dysmenorrhea
Secondary Dysmenorrhea 

A full Report of Dysmenorrhea Treatment Market is Available @ https://www.omrglobal.com/industry-reports/dysmenorrhea-treatment-market

Dysmenorrhea Treatment Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Company Profiles 

Bayer AG
Hoffmann-La Roche Ltd
SANOFI
Alvogen Iceland
Pfizer Inc.
ObsEva
Nobelpharma Co., Ltd
Color Seven Co., Ltd.
Sun Pharmaceutical Industries Limited
Beurer GmbH
Abbott Laboratories
Taj Pharmaceuticals Ltd
Myovant Sciences GmbH
AbbVie Inc.
Janssen Pharmaceuticals, Inc. 
At Lupin Inc.
Cumberland Pharmaceuticals Inc.
BioElectronics Corporation
GlaxoSmithKline plc.
Merck & Co., Inc.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dysmenorrhea Treatment Market Outlook 2029: Presents Market Insights & Depth Analysis here

News-ID: 3252420 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Dysmenorrhea

Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:  The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major
Dysmenorrhea - Drug Pipeline Landscape, 2022
Global Dysmenorrhea Market report from Global Insight Services is the single authoritative source of intelligence on Dysmenorrhea market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause